Literature DB >> 2977123

Astrocytes as eicosanoid-producing cells.

S Murphy1, B Pearce, J Jeremy, P Dandona.   

Abstract

A variety of prostaglandins and leukotrienes, together with thromboxane and prostacyclin metabolites, can be detected in central nervous tissues and in cerebrospinal fluid. Defined cultures of astrocytes have revealed these cells to be a major source of eicosanoids. In common with other eicosanoid-producing cells, agents such as calcium ionophores and phorbol esters are potent stimuli for promoting release. While in other tissues agonists for receptors linked to calcium mobilisation prompt eicosanoid release, this does not seem to be the case in astrocytes, though a range of such receptors are present. The notable exceptions to this observation are adenosine triphosphate and adenosine diphosphate, presumably acting through P2 purinergic receptors. Many cell types in the CNS are targets for eicosanoids, possessing receptors linked to adenylate cyclase or phospholipase C. An appreciation of the functional significance of activation of these receptors is just now beginning. Eicosanoids have effects in the CNS that involve not only the vascular supply but also synaptic modulation and immune regulation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2977123     DOI: 10.1002/glia.440010402

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  15 in total

Review 1.  Astrocytes as secretory cells of the central nervous system: idiosyncrasies of vesicular secretion.

Authors:  Alexei Verkhratsky; Michela Matteoli; Vladimir Parpura; Jean-Pierre Mothet; Robert Zorec
Journal:  EMBO J       Date:  2016-01-12       Impact factor: 11.598

2.  Effects of maturation on the phospholipid and phospholipid fatty acid compositions in primary rat cortical astrocyte cell cultures.

Authors:  E J Murphy; T A Rosenberger; L A Horrocks
Journal:  Neurochem Res       Date:  1997-10       Impact factor: 3.996

3.  Involvement of transforming growth factor alpha in the release of luteinizing hormone-releasing hormone from the developing female hypothalamus.

Authors:  S R Ojeda; H F Urbanski; M E Costa; D F Hill; M Moholt-Siebert
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

4.  An epoxide hydrolase inhibitor, 12-(3-adamantan-1-yl-ureido)dodecanoic acid (AUDA), reduces ischemic cerebral infarct size in stroke-prone spontaneously hypertensive rats.

Authors:  Anne M Dorrance; Nicole Rupp; David M Pollock; John W Newman; Bruce D Hammock; John D Imig
Journal:  J Cardiovasc Pharmacol       Date:  2005-12       Impact factor: 3.105

Review 5.  Astroglial vesicular network: evolutionary trends, physiology and pathophysiology.

Authors:  R Zorec; V Parpura; A Verkhratsky
Journal:  Acta Physiol (Oxf)       Date:  2017-08-03       Impact factor: 6.311

Review 6.  Physiology of Astroglia.

Authors:  Alexei Verkhratsky; Maiken Nedergaard
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

7.  Serum deprivation and re-addition: effects on cyclooxygenase inhibitor sensitivity in cultured glia.

Authors:  James Phillips; Brian Pearce
Journal:  Inflammopharmacology       Date:  2005       Impact factor: 4.473

8.  Clearance and metabolism of arachidonic acid by C6 glioma cells and astrocytes.

Authors:  F Staub; A Winkler; J Peters; U Goerke; O Kempski; A Baethmann
Journal:  Neurochem Res       Date:  1995-12       Impact factor: 3.996

9.  Matrix metalloproteinase-9 deficiency leads to prolonged foreign body response in the brain associated with increased IL-1beta levels and leakage of the blood-brain barrier.

Authors:  Weiming Tian; Themis R Kyriakides
Journal:  Matrix Biol       Date:  2009-03-03       Impact factor: 11.583

10.  Expression of enzymes involved in the prostanoid metabolism by cortical astrocytes after LPS-induced inflammation.

Authors:  Sonja Johann; Eric Kampmann; Bernd Denecke; Susanne Arnold; Markus Kipp; Jörg Mey; Cordian Beyer
Journal:  J Mol Neurosci       Date:  2008-01-03       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.